Revolutionary Technology combines Optical Microscope with Mass Spectrometer 

Shimadzu has released the iMScope TRIO for sale in Europe. The iMScope TRIO revolutionary technology combines an optical microscope together with a mass spectrometer. It is applied to cutting-edge R&D and identifies what users see at the molecular level. iMScope TRIO features extensive functionality for structural analysis through highly accurate MSn analysis.

With three proprietary features (mass spectrometry imaging, integration with optical images, and qualitative analysis), the iMScope TRIO targets applications in life science research organisations, universities, pharmaceutical companies and food as well as manufacturing industries.

Shimadzu is pursuing cooperative research with research agencies to develop more applications for basic research including cancer research and brain function analysis, drug delivery systems (DDS), metabolomics, forensic medicine and lipid analysis. Together with the National Cancer Center in Japan, cutting-edge research results have been obtained that are expected to contribute to ultra-early diagnosis of diseases and drug discovery.

The iMScope TRIO is capable of overlaying observation images from an optical microscope and molecular distribution images obtained by mass spectrometry under atmospheric pressure conditions of ionisation which feature a high resolution of 5 mm or less, the best in the world. This enables detailed analysis of regions of interest, including observation of the lesion area and distribution of anti-cancer drugs.

Enabling high accuracy and precision mass spectrometry, the iMScope TRIO provides high level qualitative analysis via the IT-TOF function, which integrates ion trap (IT) mass spectrometry for MSn analysis with time-of-flight (TOF) mass spectrometry. Not only limited to imaging samples, the system is also capable of analysing samples extracted and separated from tissues via connection with a liquid chromatograph.